Binliang Liu

688 total citations
34 papers, 384 citations indexed

About

Binliang Liu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Binliang Liu has authored 34 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Binliang Liu's work include Cancer Genomics and Diagnostics (15 papers), Advanced Breast Cancer Therapies (10 papers) and HER2/EGFR in Cancer Research (7 papers). Binliang Liu is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Advanced Breast Cancer Therapies (10 papers) and HER2/EGFR in Cancer Research (7 papers). Binliang Liu collaborates with scholars based in China, United States and United Kingdom. Binliang Liu's co-authors include Fei Ma, Xiuwen Guan, Zongbi Yi, Lixi Li, Xiaoying Sun, Haili Qian, Binghe Xu, Yanfang Guan, Chunxiao Li and Binghe Xu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Binliang Liu

30 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Binliang Liu China 12 228 183 134 134 43 34 384
Eriseld Krasniqi Italy 10 197 0.9× 99 0.5× 93 0.7× 95 0.7× 42 1.0× 21 342
Yassine Belloum Germany 7 160 0.7× 273 1.5× 190 1.4× 111 0.8× 14 0.3× 8 423
Giorgia Guaitoli Italy 12 229 1.0× 121 0.7× 146 1.1× 162 1.2× 16 0.4× 27 436
Cédric van Marcke Belgium 12 156 0.7× 165 0.9× 124 0.9× 92 0.7× 22 0.5× 34 370
Nancy Mills United States 7 176 0.8× 109 0.6× 150 1.1× 121 0.9× 16 0.4× 11 334
Shaheenah Dawood United Arab Emirates 9 219 1.0× 165 0.9× 66 0.5× 70 0.5× 21 0.5× 21 326
Miguel Bongera Spain 13 221 1.0× 196 1.1× 143 1.1× 85 0.6× 33 0.8× 23 435
Mitsuro Fukuhara Japan 12 247 1.1× 113 0.6× 110 0.8× 200 1.5× 30 0.7× 35 460
Héctor Aquiles Maldonado-Martínez Mexico 11 106 0.5× 132 0.7× 119 0.9× 82 0.6× 11 0.3× 23 296
Huiyu Lu China 11 144 0.6× 76 0.4× 120 0.9× 82 0.6× 35 0.8× 29 303

Countries citing papers authored by Binliang Liu

Since Specialization
Citations

This map shows the geographic impact of Binliang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binliang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binliang Liu more than expected).

Fields of papers citing papers by Binliang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binliang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binliang Liu. The network helps show where Binliang Liu may publish in the future.

Co-authorship network of co-authors of Binliang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Binliang Liu. A scholar is included among the top collaborators of Binliang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binliang Liu. Binliang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Xie, Ning, Dehua Liao, Binliang Liu, et al.. (2024). Interpretable Machine Learning Algorithms Identify Inetetamab‐Mediated Metabolic Signatures and Biomarkers in Treating Breast Cancer. Journal of Clinical Laboratory Analysis. 38(23). e25124–e25124. 2 indexed citations
4.
Liu, Binliang, Ning Xie, Liping Liu, et al.. (2024). Beyond clinical trials: CDK4/6 inhibitor efficacy predictors and nomogram model from real‐world evidence in metastatic breast cancer. SHILAP Revista de lepidopterología. 3(6). e143–e143. 3 indexed citations
5.
6.
7.
Zeng, Chenye, Binliang Liu, Liyuan Li, et al.. (2023). Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling. Acta Pharmaceutica Sinica B. 13(6). 2680–2700. 25 indexed citations
8.
9.
Liu, Binliang, Bo Lan, Xiaoying Sun, et al.. (2022). Clinical value of next-generation sequencing in guiding decisions regarding endocrine therapy for advanced HR-positive/HER-2-negative breast cancer. Chinese Journal of Cancer Research. 34(3). 343–352. 4 indexed citations
10.
Hu, Zhe-Yu, Yu Tang, Liping Liu, et al.. (2022). Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study. EClinicalMedicine. 51. 101567–101567. 6 indexed citations
11.
Tang, Yu, et al.. (2022). Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC. Frontiers in Endocrinology. 13. 1075830–1075830. 4 indexed citations
12.
Yi, Zongbi, Fei Ma, Guohua Rong, et al.. (2021). The molecular tumor burden index as a response evaluation criterion in breast cancer. Signal Transduction and Targeted Therapy. 6(1). 251–251. 31 indexed citations
13.
Guan, Xiuwen, Chunxiao Li, Yiqun Li, et al.. (2021). Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer. Frontiers in Oncology. 11. 602222–602222. 9 indexed citations
14.
Mo, Hongnan, Xiaobing Wang, Fei Ma, et al.. (2020). Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer. The Breast. 53. 111–118. 10 indexed citations
15.
16.
Liu, Binliang, Xiaoying Sun, Yanfeng Wang, et al.. (2020). Development and Validation of a New Clinical Prediction Model of Catheter-Related Thrombosis Based on Vascular Ultrasound Diagnosis in Cancer Patients. Frontiers in Cardiovascular Medicine. 7. 571227–571227. 11 indexed citations
17.
18.
Yi, Zongbi, Fei Ma, Binliang Liu, et al.. (2019). Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study. BMC Cancer. 19(1). 442–442. 29 indexed citations
19.
Liu, Binliang, Zongbi Yi, Xiuwen Guan, Fei Ma, & Yi‐Xin Zeng. (2017). The relationship between statins and breast cancer prognosis varies by statin type and exposure time: A meta-analysis.. Journal of Clinical Oncology. 35(15_suppl). e21606–e21606. 1 indexed citations
20.
Yi, Zongbi, Fei Ma, Chunxiao Li, et al.. (2017). Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis. Scientific Reports. 7(1). 5995–5995. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eriseld Krasniqi Breakdown of academic impact, for papers by Yassine Belloum Breakdown of academic impact, for papers by Giorgia Guaitoli Breakdown of academic impact, for papers by Cédric van Marcke Breakdown of academic impact, for papers by Nancy Mills Breakdown of academic impact, for papers by Shaheenah Dawood Breakdown of academic impact, for papers by Miguel Bongera Breakdown of academic impact, for papers by Mitsuro Fukuhara Breakdown of academic impact, for papers by Héctor Aquiles Maldonado-Martínez Breakdown of academic impact, for papers by Huiyu Lu
Rankless by CCL
2026